Virginie Robert1, Emily Triffaux1, Pierre-Emmanuel Paulet1, Jean-Charles Guéry1, Lucette Pelletier2, Magali Savignac3. 1. INSERM U1043, CNRS U5282, University Paul Sabatier, Center of Physiopathology from Toulouse Purpan, Toulouse, France. 2. INSERM U1043, CNRS U5282, University Paul Sabatier, Center of Physiopathology from Toulouse Purpan, Toulouse, France. Electronic address: lucette.pelletier@inserm.fr. 3. INSERM U1043, CNRS U5282, University Paul Sabatier, Center of Physiopathology from Toulouse Purpan, Toulouse, France. Electronic address: magali.savignac@inserm.fr.
Abstract
BACKGROUND: In addition to calcium release-activated calcium channel/ORAI calcium channels, the role of voltage-gated calcium (Cav1) channels in T-cell calcium signaling is emerging. Cav1 channels are formed by α1 (CaV1.1 to CaV1.4) and auxiliary subunits. We previously demonstrated that mouse TH2 cells selectively overexpressed CaV1.2 and CaV1.3 channels. Knocking down these channels with Cav1 antisense (AS) oligonucleotides inhibited TH2 functions and experimental asthma. OBJECTIVE: We investigated the expression profile and role of Cav1 channels in human T-cell subsets, with a focus on TH2 cells. METHODS: We compared the profile of CaV1 channel subunit expression in T-cell subsets isolated ex vivo from the blood of healthy donors, as well as in vitro-polarized T-cell subsets, and tested the effect of the Cav1 inhibitors nicardipine and Cav1.2AS on their functions. RESULTS: CaV1.4 expression was detectable in CD4(+) T cells, ex vivo TH1 cells, and TH17 cells, whereas Cav1.2 channels predominated in TH2 cells only. T-cell activation resulted in Cav1.4 downregulation, whereas Cav1.2 expression was selectively maintained in polarized TH2 cells and absent in TH1 or TH9 cells. Nicardipine and CaV1.2AS decreased Ca(2+) and cytokine responses in TH2, but not TH1, cells. Protein kinase C (PKC) α/β inhibition decreased Ca(2+) and cytokine responses, whereas both calcium and cytokine responses induced by PKC activation were inhibited by nicardipine or Cav1.2AS in TH2 cells. CONCLUSION: This study highlights the selective expression of Cav1.2 channels in human TH2 cells and the role of PKC-dependent Cav1.2 channel activation in TH2 cell function. Blocking PKC or Cav1.2 channel activation in TH2 cells might represent new strategies to treat allergic diseases in human subjects.
BACKGROUND: In addition to calcium release-activated calcium channel/ORAI calcium channels, the role of voltage-gated calcium (Cav1) channels in T-cell calcium signaling is emerging. Cav1 channels are formed by α1 (CaV1.1 to CaV1.4) and auxiliary subunits. We previously demonstrated that mouseTH2 cells selectively overexpressed CaV1.2 and CaV1.3 channels. Knocking down these channels with Cav1 antisense (AS) oligonucleotides inhibited TH2 functions and experimental asthma. OBJECTIVE: We investigated the expression profile and role of Cav1 channels in human T-cell subsets, with a focus on TH2 cells. METHODS: We compared the profile of CaV1 channel subunit expression in T-cell subsets isolated ex vivo from the blood of healthy donors, as well as in vitro-polarized T-cell subsets, and tested the effect of the Cav1 inhibitors nicardipine and Cav1.2AS on their functions. RESULTS:CaV1.4 expression was detectable in CD4(+) T cells, ex vivo TH1 cells, and TH17 cells, whereas Cav1.2 channels predominated in TH2 cells only. T-cell activation resulted in Cav1.4 downregulation, whereas Cav1.2 expression was selectively maintained in polarized TH2 cells and absent in TH1 or TH9 cells. Nicardipine and CaV1.2AS decreased Ca(2+) and cytokine responses in TH2, but not TH1, cells. Protein kinase C (PKC) α/β inhibition decreased Ca(2+) and cytokine responses, whereas both calcium and cytokine responses induced by PKC activation were inhibited by nicardipine or Cav1.2AS in TH2 cells. CONCLUSION: This study highlights the selective expression of Cav1.2 channels in humanTH2 cells and the role of PKC-dependent Cav1.2 channel activation in TH2 cell function. Blocking PKC or Cav1.2 channel activation in TH2 cells might represent new strategies to treat allergic diseases in human subjects.
Authors: Huiyun Wang; Xuexin Zhang; Li Xue; Juan Xing; Marie-Hélène Jouvin; James W Putney; Matthew P Anderson; Mohamed Trebak; Jean-Pierre Kinet Journal: Immunity Date: 2016-03-29 Impact factor: 31.745
Authors: Lauren Z Atkinson; Lucy Colbourne; Alexander Smith; Catherine H Harmer; Anna C Nobre; Jennifer Rendell; Helen Jones; Christopher Hinds; Arne Mould; Elizabeth M Tunbridge; Andrea Cipriani; John R Geddes; Kate E A Saunders; Paul J Harrison Journal: Trials Date: 2019-02-12 Impact factor: 2.279
Authors: Serap Erdogmus; Axel R Concepcion; Megumi Yamashita; Ikjot Sidhu; Anthony Y Tao; Wenyi Li; Pedro P Rocha; Bonnie Huang; Ralph Garippa; Boram Lee; Amy Lee; Johannes W Hell; Richard S Lewis; Murali Prakriya; Stefan Feske Journal: Nat Commun Date: 2022-04-19 Impact factor: 17.694